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Background
Tuberculosis remains a common condition in children
worldwide. Adequate treatment requires multiple antibio-
tics for several months. Hypersensitivity/adverse reactions
to antituberculosis drugs can interfere with continuity of
treatment and result in severe reactions.
Case report
A ten years old boy was admitted for pleural tuberculosis
(negative cultures, positive quantiferon assay, and father
under treatment for tuberculosis). On the tenth day of
treatment with isoniazid, rifampicin and pyrazinamide he
develloped an exuberant urticarial rash, facial oedema,
fever, myalgias, oliguria and, later, conjunctival hyperemia.
Laboratory results included low platelet count, hypoalbu-
minemia and hyponatremia. Gradual improvement
occured after suspension of treatment. One month later,
drugs were gradualy re-introduced (1 drug/week) but
several reactions occurred: anaphylaxis 5 hours after
rifampicin administration and generalized macular rash
after pyrazinamide. Both drugs were suspended. Isoniazid
caused an initial light generalized macular exanthema.
Streptomycin, ethambutol and ciprofloxacin were intro-
duced and well tolerated. In subsequent evaluation the
child was asymptomatic, with normal analytic results and
radiologic improvement. After 6 months of successful
treatment, he was tested in detail for reactions to the
implicated drugs.
Discussion
Reactions to antituberculosis drugs occur with variable
frequency and severity, and may result from a single drug
or the interaction of two or more. In this case, a severe
reaction to the association of rifampicin and isoniazid
seems to have occurred. Haematological disorders
associated with rifampicin are a contraindication to
reintroduction/tolerance induction of the drug so skin
tests were not performed. Skin prick tests and intradermal
tests to isoniazid were negative. Pyrazinamide reaction was
only cutaneous and there are no validated tests to confirm
diagnosis. This case shows the difficulty in continuity of
treatment when hypersensitivity/adverse reactions occur.
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